Page last updated: 2024-11-02

piribedil and Bradyarrhythmia

piribedil has been researched along with Bradyarrhythmia in 1 studies

Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

Research Excerpts

ExcerptRelevanceReference
"No studies have previously reported the simultaneous observation of position-unrelated hypotension and bradycardia after taking small doses of piribedil."8.98Hypotension and bradycardia, a serious adverse effect of piribedil, a case report and literature review. ( Li, Y; Nie, K; Wang, L; Zhang, P; Zhang, Y, 2018)
"No studies have previously reported the simultaneous observation of position-unrelated hypotension and bradycardia after taking small doses of piribedil."4.98Hypotension and bradycardia, a serious adverse effect of piribedil, a case report and literature review. ( Li, Y; Nie, K; Wang, L; Zhang, P; Zhang, Y, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, P1
Li, Y1
Nie, K1
Wang, L1
Zhang, Y1

Reviews

1 review available for piribedil and Bradyarrhythmia

ArticleYear
Hypotension and bradycardia, a serious adverse effect of piribedil, a case report and literature review.
    BMC neurology, 2018, Dec-27, Volume: 18, Issue:1

    Topics: Bradycardia; Dopamine; Dopamine Agonists; Humans; Hypotension; Male; Middle Aged; Parkinson Disease;

2018